UNI universal store holdings limited

looking very good, page-18

  1. 1,480 Posts.
    UNI's partners...
    times are tough with friends like...

    Gerresheimer is a leading supplier to the pharma & life science industry and the cosmetics industry, with leading market positions in the field of specialty products based on glass and plastic. The Group employs more than 10,800 people in 41 locations in Europe, America and Asia. Worldwide sales in the financial year 2007 totalled €958m.

    2007 Top 20 Pharmaceutical Companies Report

    Pfizer's at the top of the roost, but one hare-brained mega-acquisition by GlaxoSmithKline or Sanofi could topple them. Companies #2-5 are all foreign, but seven of the next eight are based in the U.S.; I have no idea what that's supposed to signify. Demonstrating how tough it is to stay at the top, only four companies in the top 10 reached double-digit sales growth.
    The largest increase in revenues was Novartis' $3.3 billion, but almost 30% of that came from its purchase of Chiron. GSK had the greatest "organic"  growth, adding $3.0 billion in revenues. Bristol-Myers Squibb and Abbott Laboratories suffered the most last year, shedding $1.4 billion and $1.3 billion in revenues, respectively.


    Top 20 Pharmaceutical Companies

    01 Pfizer $45,083
    02 GlaxoSmithKline $37,003
    03 Sanofi-Aventis $35,643
    04 AstraZeneca $25,741
    05 Novartis $23,532
    06 Merck $23,425
    07 Johnson & Johnson $23,267
    08 Roche $19,300
    09 Wyeth $15,683
    10 Eli Lilly & Co. $14,816
    11 Bristol-Myers Squibb $13,861
    12 Abbott Laboratories $12,395
    13 Schering-Plough $10,461
    14 Boehringer-Ingelheim $10,440
    15 Takeda $9,793
    16 Bayer AG $8,518
    17 Astellas $7,862
    18 Daiichi-Sankyo $7,166
    19 Eisai $5,589
    20 Merck KgA $4,674










 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$8.04
Change
0.010(0.12%)
Mkt cap ! $616.8M
Open High Low Value Volume
$8.05 $8.13 $7.96 $261.3K 32.49K

Buyers (Bids)

No. Vol. Price($)
1 1514 $7.98
 

Sellers (Offers)

Price($) Vol. No.
$8.15 5049 2
View Market Depth
Last trade - 16.10pm 14/07/2025 (20 minute delay) ?
UNI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.